Leeds news LIVE: Fourth Covid-19 Novavax vaccine could be approved for use in the UK within weeks
A fourth Covid-19 vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89 per cent effective in preventing coronavirus
The UK has secured 60 million doses of the Novavax jab – to be produced on Teesside – which is believed to offer protection against the new UK and South African variants.
